Thermage Calls Syneron Countersuit Without Merit

Thermage, a leader in innovative aesthetic devices based on proprietary radiofrequency technology, today characterized the countersuit filed on January 10, 2005, by Syneron as without merit. In July 2004, Thermage filed a patent infringement lawsuit against
Syneron's Aurora, Polaris, and Galaxy systems. Thermage claims Syneron
infringes six patents.

"Syneron has resorted to a common tactic of deflecting attention from its
own infringement by purchasing and asserting an old patent from a third party
that discloses technology fundamentally different from that invented and used
by Thermage," said Thermage President and CEO Bob Byrnes. "This is an attempt
to distract stakeholders from the merits of our own very strong infringement
lawsuit against Syneron, which is based on six solid patents containing over
100 claims," stated Byrnes.

Thermage commercially launched its ThermaCool(TM) system for tissue
tightening and contouring in July 2002 and now has over 1200 systems installed
worldwide. In June 2004, the ThermaCool system received FDA clearance for
full-face treatment, adding to the clearance obtained in November 2002 for
treatment of periorbital (around the eyes) wrinkles and rhytids.

The ThermaCool system uses capacitive radiofrequency (CRF) technology to
non-invasively generate deep, uniform, volumetric heating of surface tissue to
tighten and contour both skin and underlying tissue, while protecting the
skin's outer layer with a cooling cryogen spray. The deep volumetric heating
action promotes immediate collagen contraction beneath the skin surface and
generates new collagen growth over time.